Article
RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance
3 Oct 2019
Abstract excerpt
We have previously demonstrated that loss of the tumor suppressive activity of ribosomal protein (RP) RPL22 predisposes to development of leukemia in mouse models and aggressive disease in human patients; however, the role of RPL22 in solid tumors, specifically colorectal cancer (CRC), had not been explored. We report here that RPL22 is either deleted or mutated in 36% of CRC and provide new insights into its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
